Rafael Blesa - Sant Pau Memory Unit - Alzheimer Research - Barcelona

Rafael Blesa

Rafael Blesa GonzalezDr. Rafael Blesa obtained his medical degree from the Universitat Autònoma de Barcelona in 1975 and specialized in Neurology at Hospital de la Santa Creu i Sant Pau.

After completing his Ph.D. in Medicine at the Universitat de Barcelona (1989) he worked at the National Institute of Health in Bethesda, Maryland (USA) as an associate researcher in experimental therapies. He returned to Barcelona in 1993 where he directed the Alzheimer and Other Cognitive Disorders Unit at Hospital Clínic for 10 years. Since 2003, Dr Blesa has been the Director of the Neurology Department at Hospital de la Santa Creu i Sant Pau.

Dr. Rafael Blesa is the author of more than 30 book chapters and more than 170 scientific articles published in high impact national and international journals, and he has been the principal investigator of over 70 research projects and pharmacological studies in the field of Alzheimer’s disease. He is a member of prestigious medical and scientific societies that have awarded his scientific contributions in numerous occasions.

In his professional trajectory, he has combined clinical and research tasks with teaching activities as an associate professor of Neurology at Universitat de Barcelona and Universitat Autònoma de Barcelona, and he has directed and supervised numerous doctoral theses.

Currently, besides directing the Neurology Department, Dr. Rafael Blesa is the principal investigator of the advanced therapies research line within the Memory Unit.

Recent Publications

  1. Improving Education and Training to Reduce the Burden of Occupational Cancer. The Riga-European Association of Schools of Occupational Medicine (EASOM) Statement on Work-Related Cancer. Martínez-Jarreta, B et al. Int J Environ Res Public Health 2020

  2. Reactivity Study of a Biodegradable Polydioxanone Tracheal Stent in a Rabbit Model. Rodriguez-Zapater, S et al. Arch. Bronconeumol. 2020

  3. [Examination of vitiligo using the blue light from the screen of mobile devices as an alternative to a Wood's lamp]. García-Gil, MF et al. Aten Primaria 2020

  4. Tuberculosis in a Spanish cohort of children living with HIV: the CHOTIS study (Childhood HIV & TB study). López-Medina, EM et al. Int. J. Tuberc. Lung Dis. 2020

  5. Colonic diverticular disease. Tursi, A et al. Nat Rev Dis Primers 2020

  6. Assessment of Health Information About COVID-19 Prevention on the Internet: Infodemiological Study. Hernández-García, I et al. JMIR Public Health Surveill 2020

  7. Towards evidence-based and personalised care of acute pancreatitis. García-Rayado, G et al. United European Gastroenterol J 2020

  8. Sex Differences in Comorbidity, Therapy, and Health Services' Use of Heart Failure in Spain: Evidence from Real-World Data. Gracia Gutiérrez, A et al. Int J Environ Res Public Health 2020

  9. Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis. Cuenca, I et al. Leukemia 2020

  10. Switching to a second thiopurine in adult and elderly patients with inflammatory bowel disease: a nationwide study from the ENEIDA registry. Calafat, M et al. J Crohns Colitis 2020

  11. Leucocytoclastic vasculitis secondary to new oral anticoagulants. Martínez Pallás, I et al. Rev Clin Esp 2020

  12. Prognostic value of multimodal assessment of congestion in acute heart failure. Rubio-Gracia, J et al. Rev Clin Esp 2020

  13. Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: the importance of the pharmacotherapeutic history. García-Gil, MF et al. Postgrad Med J 2020

  14. Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation. Rubio-Rivas, M et al. Autoimmun Rev 2020

  15. Delineation of phenotypes and genotypes related to cohesin structural protein RAD21. Krab, LC et al. Hum. Genet. 2020

Search PubMed